Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA – Get Free Report) were down 1.6% during trading on Monday . The stock traded as low as $9.02 and last traded at $9.06. Approximately 3,751,281 shares changed hands during mid-day trading, a decline of 77% from the average daily volume of 16,016,987 shares. The stock had previously closed at $9.21.
Analyst Ratings Changes
Several equities analysts have commented on WBA shares. Barclays decreased their target price on shares of Walgreens Boots Alliance from $11.00 to $7.00 and set an “underweight” rating on the stock in a report on Tuesday, July 23rd. UBS Group decreased their price target on shares of Walgreens Boots Alliance from $17.00 to $12.00 and set a “neutral” rating on the stock in a report on Wednesday, July 3rd. JPMorgan Chase & Co. decreased their price target on shares of Walgreens Boots Alliance from $20.00 to $15.00 and set an “overweight” rating on the stock in a report on Friday, August 30th. Morgan Stanley decreased their price target on shares of Walgreens Boots Alliance from $13.00 to $9.00 and set an “underweight” rating on the stock in a report on Friday, June 28th. Finally, Evercore ISI decreased their price target on shares of Walgreens Boots Alliance from $17.00 to $10.00 and set an “in-line” rating on the stock in a report on Friday, June 28th. Four equities research analysts have rated the stock with a sell rating, ten have given a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat.com, Walgreens Boots Alliance currently has a consensus rating of “Hold” and an average target price of $14.73.
Get Our Latest Research Report on WBA
Walgreens Boots Alliance Stock Down 0.6 %
Walgreens Boots Alliance (NASDAQ:WBA – Get Free Report) last issued its quarterly earnings results on Thursday, June 27th. The pharmacy operator reported $0.63 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.68 by ($0.05). The firm had revenue of $36.40 billion during the quarter, compared to analyst estimates of $35.94 billion. Walgreens Boots Alliance had a positive return on equity of 12.63% and a negative net margin of 3.99%. The firm’s revenue for the quarter was up 2.8% on a year-over-year basis. During the same quarter last year, the firm posted $1.00 EPS. On average, sell-side analysts expect that Walgreens Boots Alliance, Inc. will post 2.86 earnings per share for the current year.
Walgreens Boots Alliance Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Thursday, September 12th. Investors of record on Wednesday, August 21st were given a dividend of $0.25 per share. The ex-dividend date was Wednesday, August 21st. This represents a $1.00 dividend on an annualized basis and a dividend yield of 11.10%. Walgreens Boots Alliance’s payout ratio is presently -14.84%.
Institutional Inflows and Outflows
Institutional investors have recently modified their holdings of the stock. Newbridge Financial Services Group Inc. raised its holdings in Walgreens Boots Alliance by 41.3% during the second quarter. Newbridge Financial Services Group Inc. now owns 13,050 shares of the pharmacy operator’s stock worth $158,000 after buying an additional 3,816 shares during the last quarter. Sanctuary Advisors LLC acquired a new position in Walgreens Boots Alliance during the second quarter worth $313,000. Strategic Investment Solutions Inc. IL acquired a new position in Walgreens Boots Alliance during the second quarter worth $34,000. Cetera Investment Advisers raised its holdings in Walgreens Boots Alliance by 4.4% during the second quarter. Cetera Investment Advisers now owns 364,734 shares of the pharmacy operator’s stock worth $4,411,000 after buying an additional 15,270 shares during the last quarter. Finally, William B. Walkup & Associates Inc. acquired a new position in Walgreens Boots Alliance during the second quarter worth $821,000. Institutional investors and hedge funds own 58.59% of the company’s stock.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.
Featured Articles
- Five stocks we like better than Walgreens Boots Alliance
- Profitably Trade Stocks at 52-Week Highs
- How Much Can You Make in Stocks in One Month?
- Canada Bond Market Holiday: How to Invest and Trade
- This Is the Top Large-Cap Stock Insiders Are Buying
- What Do S&P 500 Stocks Tell Investors About the Market?
- Capitalize on Micron’s 24% Drop—Wall Street Eyes Major Upside
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.